Dactinomycin Global Market Report 2025

Description

Dactinomycin is an antitumor antibiotic obtained from the bacterium Streptomyces parvulus. It functions by binding to deoxyribonucleic acid (DNA) and inhibiting ribonucleic acid (RNA) synthesis, thereby hindering cell replication. It is primarily used in chemotherapy for various cancers, such as testicular cancer and sarcomas. Its use may result in side effects, including bone marrow suppression and gastrointestinal disturbances.

Dactinomycin is available mainly in two forms injections and implants. Injections involve administering dactinomycin as a solution directly into the bloodstream, muscle, or tumor to disrupt DNA replication. Its applications include alkylating agents, hormones, and plant medicine. The primary end users are hospitals, cancer treatment centers, and research institutions.

The dactinomycin market research report is one of a series of new reports from the business research company that provides dactinomycin market statistics, including dactinomycin industry global market size, regional shares, competitors with an dactinomycin market share, detailed dactinomycin market segments, market trends and opportunities, and any further data you may need to thrive in the dactinomycin industry. This dactinomycin market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The dactinomycin market size has grown steadily in recent years. It will grow from $6.76 billion in 2024 to $6.98 billion in 2025 at a compound annual growth rate (CAGR) of 3.1%. The growth in the historic period can be attributed to the discovery of actinomycin's, clinical development and approval, development in pediatric oncology, ongoing research, and evolution of chemotherapy.

The dactinomycin market size is expected to see steady growth in the next few years. It will grow to $7.81 billion in 2029 at a compound annual growth rate (CAGR) of 2.9%. The growth in the forecast period can be attributed to the incidence and prevalence of target cancers, market access and reimbursement, cost-effectiveness, new drug delivery systems, and healthcare access and infrastructure. Major trends in the forecast period include personalized medicine, new formulations, bioinformatics and data analytics, advances in biomarker discovery, and imaging and monitoring technologies.

The increasing incidence of cancer is projected to drive growth in the dactinomycin market. Factors contributing to the rise in cancer cases include an aging population, lifestyle choices, environmental factors, and genetic predisposition. Dactinomycin plays a crucial role in cancer treatment by inhibiting DNA transcription, which disrupts the proliferation of cancer cells and helps reduce tumor growth. For instance, the World Health Organization reported in February 2024 that by 2050, more than 35 million new cancer cases are expected, representing a 77% increase from an estimated 20 million cases in 2022. Consequently, the rising cancer incidence is propelling the growth of the dactinomycin market.

The growth of the dactinomycin market is expected to be driven by the expansion of healthcare infrastructure. Healthcare infrastructure encompasses the physical and organizational structures, facilities, resources, and systems essential for delivering healthcare services to populations. This expansion is fueled by factors such as an aging global population, the rise in chronic diseases, and advancements in technology. Robust healthcare infrastructure supports the use of dactinomycin by ensuring its availability in oncology centers, enabling timely treatment for pediatric and rare cancers, and facilitating advanced chemotherapy protocols. For example, the American Hospital Association reported in January 2024 that the United States had 6,120 hospitals, with 916,752 staffed beds and 33,679,935 total admissions in 2024. Similarly, a report by the UK's Office for National Statistics in May 2024 highlighted a 5.6% nominal increase in healthcare expenditure from 2022 to 2023, compared to 0.9% growth in 2022, and a 2.8% real-term increase in long-term health and social care expenditure in 2022. These developments underscore how the expansion of healthcare infrastructure is propelling the dactinomycin market forward.

In May 2024, Empower Pharma, a US-based pharmaceutical company, acquired manufacturing assets from Eugia US LLC, a subsidiary of Aurobindo Pharma Ltd., for $52 million. This strategic acquisition aims to enhance Empower Pharma's capabilities in sterile medication manufacturing and further its growth objectives in the pharmaceutical sector, particularly in personalized medicine. Eugia US LLC specializes in manufacturing dactinomycin drug injections.

Major companies operating in the dactinomycin market are Merck KGaA, Baxter International Inc., Teva Pharmaceutical Industries Limited, Recordati Rare Diseases Inc., Zhejiang Hisun Pharmaceutical Co. Ltd., Concord Biotech Limited, Celon Laboratories Limited, Prasco LLC, Cayman Chemical Company, Santa Cruz Biotechnology Inc., Rochem International Inc., AdvaCare International, Health Biotech Limited, Neon Laboratories Ltd, X-GEN Pharmaceuticals Inc., Florencia Healthcare, SGPharma Pvt. Ltd., BOC Sciences, Manus Aktteva Biopharma LLP, Angle Bio Pharma, Enomark Healthcare Pvt. Ltd., Meitheal Pharmaceuticals Inc

North America was the largest region in the dactinomycin market in 2023. The regions covered in the dactinomycin market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the dactinomycin market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The dactinomycin market consists of sales of generic versions, formulations, and dactinomycin-related combinations. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Dactinomycin Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on dactinomycin market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for dactinomycin ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The dactinomycin market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Type: Injection; Implants
2) By Application: Alkylating Agent; Hormone; Plant Medicine
3) By End User: Hospitals; Cancer Treatment Centers; Research Institutions
Subsegments:
1) By Injection: Intravenous Injection; Intramuscular Injection; Subcutaneous Injection
2) By Implants: Sustained Release Implants; Biodegradable Implants; Non-biodegradable Implants
Companies Mentioned: Merck KGaA; Baxter International Inc.; Teva Pharmaceutical Industries Limited; Recordati Rare Diseases Inc.; Zhejiang Hisun Pharmaceutical Co. Ltd.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r31769

1. Executive Summary

2. Dactinomycin Market Characteristics

3. Dactinomycin Market Trends And Strategies

4. Dactinomycin Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Dactinomycin Growth Analysis And Strategic Analysis Framework

5.1. Global Dactinomycin PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Dactinomycin Market Growth Rate Analysis
5.4. Global Dactinomycin Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Dactinomycin Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Dactinomycin Total Addressable Market (TAM)

6. Dactinomycin Market Segmentation

6.1. Global Dactinomycin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Injection
Implants
6.2. Global Dactinomycin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Alkylating Agent
Hormone
Plant Medicine
6.3. Global Dactinomycin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Cancer Treatment Centers
Research Institutions
6.4. Global Dactinomycin Market, Sub-Segmentation Of Injection, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Intravenous Injection
Intramuscular Injection
Subcutaneous Injection
6.5. Global Dactinomycin Market, Sub-Segmentation Of Implants, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Sustained Release Implants
Biodegradable Implants
Non-biodegradable Implants

7. Dactinomycin Market Regional And Country Analysis

7.1. Global Dactinomycin Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Dactinomycin Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Dactinomycin Market

8.1. Asia-Pacific Dactinomycin Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Dactinomycin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Dactinomycin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Dactinomycin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Dactinomycin Market

9.1. China Dactinomycin Market Overview
9.2. China Dactinomycin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Dactinomycin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Dactinomycin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Dactinomycin Market

10.1. India Dactinomycin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Dactinomycin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Dactinomycin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Dactinomycin Market

11.1. Japan Dactinomycin Market Overview
11.2. Japan Dactinomycin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Dactinomycin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Dactinomycin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Dactinomycin Market

12.1. Australia Dactinomycin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Dactinomycin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Dactinomycin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Dactinomycin Market

13.1. Indonesia Dactinomycin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Dactinomycin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Dactinomycin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Dactinomycin Market

14.1. South Korea Dactinomycin Market Overview
14.2. South Korea Dactinomycin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Dactinomycin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Dactinomycin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Dactinomycin Market

15.1. Western Europe Dactinomycin Market Overview
15.2. Western Europe Dactinomycin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Dactinomycin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Dactinomycin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Dactinomycin Market

16.1. UK Dactinomycin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Dactinomycin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Dactinomycin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Dactinomycin Market

17.1. Germany Dactinomycin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Dactinomycin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Dactinomycin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Dactinomycin Market

18.1. France Dactinomycin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Dactinomycin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Dactinomycin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Dactinomycin Market

19.1. Italy Dactinomycin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Dactinomycin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Dactinomycin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Dactinomycin Market

20.1. Spain Dactinomycin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Dactinomycin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Dactinomycin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Dactinomycin Market

21.1. Eastern Europe Dactinomycin Market Overview
21.2. Eastern Europe Dactinomycin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Dactinomycin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Dactinomycin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Dactinomycin Market

22.1. Russia Dactinomycin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Dactinomycin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Dactinomycin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Dactinomycin Market

23.1. North America Dactinomycin Market Overview
23.2. North America Dactinomycin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Dactinomycin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Dactinomycin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Dactinomycin Market

24.1. USA Dactinomycin Market Overview
24.2. USA Dactinomycin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Dactinomycin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Dactinomycin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Dactinomycin Market

25.1. Canada Dactinomycin Market Overview
25.2. Canada Dactinomycin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Dactinomycin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Dactinomycin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Dactinomycin Market

26.1. South America Dactinomycin Market Overview
26.2. South America Dactinomycin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Dactinomycin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Dactinomycin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Dactinomycin Market

27.1. Brazil Dactinomycin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Dactinomycin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Dactinomycin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Dactinomycin Market

28.1. Middle East Dactinomycin Market Overview
28.2. Middle East Dactinomycin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Dactinomycin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Dactinomycin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Dactinomycin Market

29.1. Africa Dactinomycin Market Overview
29.2. Africa Dactinomycin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Dactinomycin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Dactinomycin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Dactinomycin Market Competitive Landscape And Company Profiles

30.1. Dactinomycin Market Competitive Landscape
30.2. Dactinomycin Market Company Profiles
- 30.2.1. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Teva Pharmaceutical Industries Limited Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Recordati Rare Diseases Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Zhejiang Hisun Pharmaceutical Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis

31. Dactinomycin Market Other Major And Innovative Companies

31.1. Concord Biotech Limited
31.2. Celon Laboratories Limited
31.3. Prasco LLC
31.4. Cayman Chemical Company
31.5. Santa Cruz Biotechnology Inc.
31.6. Rochem International Inc.
31.7. AdvaCare International
31.8. Health Biotech Limited
31.9. Neon Laboratories Ltd
31.10. X-GEN Pharmaceuticals Inc.
31.11. Florencia Healthcare
31.12. SGPharma Pvt. Ltd.
31.13. BOC Sciences
31.14. Manus Aktteva Biopharma LLP
31.15. Angle Bio Pharma

32. Global Dactinomycin Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Dactinomycin Market

34. Recent Developments In The Dactinomycin Market

35. Dactinomycin Market High Potential Countries, Segments and Strategies

35.1 Dactinomycin Market In 2029 - Countries Offering Most New Opportunities
35.2 Dactinomycin Market In 2029 - Segments Offering Most New Opportunities
35.3 Dactinomycin Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer